Search

everythinglearnresearchcommunity

for

Search:↓

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with high androgen levels may have more severe COVID-19 symptoms.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

COVID-19 may harm male fertility and damage the reproductive system.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Aromatherapy uses essential oils to improve mood and well-being.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Some alopecia treatments might help treat COVID-19, but more research is needed.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Testosterone injections can cause skin darkening and thickening.